Ameriprise
IONS icon

Ameriprise’s Ionis Pharmaceuticals IONS Stock Holding History

Ameriprise’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.6M Buy
660,144
+61,396
+10% +$4.85M 0.01% 873
2025
Q4 		$47.4M Sell
598,748
-167,074
-22% -$12.6M 0.01% 913
2025
Q3 		$50.1M Buy
765,822
+397,703
+108% +$19.4M 0.01% 875
2025
Q2 		$14.5M Buy
368,119
+7,931
+2% +$260K ﹤0.01% 1547
2025
Q1 		$10.9M Sell
360,188
-27,260
-7% -$893K ﹤0.01% 1705
2024
Q4 		$13.5M Sell
387,448
-10,450
-3% -$391K ﹤0.01% 1584
2024
Q3 		$15.9M Buy
397,898
+389,106
+4,426% +$18.1M ﹤0.01% 1459
2024
Q2 		$419K Sell
8,792
-6,881
-44% -$282K ﹤0.01% 3475
2024
Q1 		$679K Sell
15,673
-9,952
-39% -$474K ﹤0.01% 3317
2023
Q4 		$1.3M Buy
25,625
+17,810
+228% +$853K ﹤0.01% 3084
2023
Q3 		$354K Sell
7,815
-1,445
-16% -$59.6K ﹤0.01% 3531
2023
Q2 		$380K Buy
9,260
+343
+4% +$13.2K ﹤0.01% 3535
2023
Q1 		$319K Sell
8,917
-4,414
-33% -$166K ﹤0.01% 3595
2022
Q4 		$501K Sell
13,331
-25,372
-66% -$1.07M ﹤0.01% 3409
2022
Q3 		$1.71M Buy
38,703
+27,319
+240% +$1.15M ﹤0.01% 2851
2022
Q2 		$421K Sell
11,384
-1,298
-10% -$48.9K ﹤0.01% 3452
2022
Q1 		$467K Buy
12,682
+3,055
+32% +$100K ﹤0.01% 3513
2021
Q4 		$293K Sell
9,627
-1,272
-12% -$40K ﹤0.01% 3680
2021
Q3 		$366K Buy
10,899
+974
+10% +$36.7K ﹤0.01% 3502
2021
Q2 		$395K Sell
9,925
-4,553
-31% -$178K ﹤0.01% 3544
2021
Q1 		$652K Sell
14,478
-781
-5% -$43.6K ﹤0.01% 3311
2020
Q4 		$865K Buy
15,259
+4,747
+45% +$237K ﹤0.01% 3147
2020
Q3 		$498K Sell
10,512
-546
-5% -$30.3K ﹤0.01% 3242
2020
Q2 		$653K Buy
11,058
+1,098
+11% +$61.1K ﹤0.01% 3094
2020
Q1 		$472K Buy
9,960
+655
+7% +$36.5K ﹤0.01% 3155
2019
Q4 		$563K Buy
9,305
+1,108
+14% +$66K ﹤0.01% 3291
2019
Q3 		$490K Buy
8,197
+329
+4% +$21.4K ﹤0.01% 3311
2019
Q2 		$506K Sell
7,868
-1,586
-17% -$112K ﹤0.01% 3334
2019
Q1 		$767K Buy
9,454
+271
+3% +$17.5K ﹤0.01% 3141
2018
Q4 		$497K Sell
9,183
-4,223
-32% -$215K ﹤0.01% 3186
2018
Q3 		$692K Sell
13,406
-131,890
-91% -$6.2M ﹤0.01% 3197
2018
Q2 		$6.05M Buy
145,296
+72,271
+99% +$3.2M ﹤0.01% 2111
2018
Q1 		$3.22M Buy
73,025
+53,490
+274% +$2.72M ﹤0.01% 2467
2017
Q4 		$983K Buy
19,535
+10,557
+118% +$579K ﹤0.01% 2978
2017
Q3 		$456K Sell
8,978
-9,774
-52% -$512K ﹤0.01% 3252
2017
Q2 		$953K Buy
18,752
+13,647
+267% +$635K ﹤0.01% 2968
2017
Q1 		$205K Sell
5,105
-10,182
-67% -$457K ﹤0.01% 3467
2016
Q4 		$731K Buy
+15,287
New +$605K ﹤0.01% 3110
2016
Q1 		– Sell
-50,962
Closed -$3.16M – 3812
2015
Q4 		$3.16M Sell
50,962
-107,013
-68% -$5.77M ﹤0.01% 2346
2015
Q3 		$6.37M Buy
157,975
+104,628
+196% +$5.42M ﹤0.01% 1825
2015
Q2 		$3.07M Sell
53,347
-79,158
-60% -$5.03M ﹤0.01% 2479
2015
Q1 		$8.44M Buy
132,505
+83,779
+172% +$5.68M ﹤0.01% 1702
2014
Q4 		$3.01M Buy
48,726
+41,723
+596% +$2.06M ﹤0.01% 2358
2014
Q3 		$272K Buy
7,003
+5,055
+259% +$179K ﹤0.01% 3266
2014
Q2 		$67K Sell
1,948
-374,699
-99% -$11.8M ﹤0.01% 3770
2014
Q1 		$16.3M Buy
376,647
+121,557
+48% +$5.89M 0.01% 1153
2013
Q4 		$10.2M Buy
255,090
+247,026
+3,063% +$8.8M 0.01% 1490
2013
Q3 		$302K Sell
8,064
-210
-3% -$6.27K ﹤0.01% 3028
2013
Q2 		$222K Buy
+8,274
New +$176K ﹤0.01% 3051

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's IONS Position: Q1 2026 in Review

Ameriprise increased its Ionis Pharmaceuticals (IONS) stake by 10% in Q1 2026, buying an estimated $4.85M and bringing the position to 660,144 shares worth $49.6M. The position accounts for 0.01% of the portfolio, ranked #873.

Ameriprise first reported a position in IONS in Q2 2013 and has held it in 49 quarters since. The position peaked at $50.1M in Q3 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Ameriprise held 660,144 shares of Ionis Pharmaceuticals worth $49.6M as of Q1 2026.
  • Ameriprise bought 61,396 Ionis Pharmaceuticals shares in Q1 2026, an estimated $4.85M.
  • Ionis Pharmaceuticals made up 0.01% of Ameriprise's portfolio in Q1 2026, its #873 holding.
  • Ameriprise first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Ameriprise's Ionis Pharmaceuticals position peaked at $50.1M in Q3 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.